[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
August 25, 2004

West Nile Virus Trials

JAMA. 2004;292(8):916. doi:10.1001/jama.292.8.916-d

The National Institute of Allergy and Infectious Diseases is expanding its clinical trial of an experimental West Nile virus (WNV) treatment. The trial opened at 36 sites last September, and it is expected to add about 24 new sites this summer.

The trial is assessing the safety of a product containing WNV antibodies derived from individuals who have high blood levels of these antibodies. These antibodies may have the potential to help patients fight WNV infections.

First Page Preview View Large
First page PDF preview
First page PDF preview
×